ELUNATEY Trademark

Trademark Overview

On Tuesday, June 24, 2014, a trademark application was filed for ELUNATEY with the United States Patent and Trademark Office. The USPTO has given the ELUNATEY trademark a serial number of 86319169. The federal status of this trademark filing is ABANDONED - NO STATEMENT OF USE FILED as of Monday, January 29, 2018. This trademark is owned by Eli Lilly and Company. The ELUNATEY trademark is filed in the Pharmaceutical Products category with the following description:

Pharmaceutical preparations, namely, pharmaceutical preparations for the treatment of autoimmune diseases and disorders
elunatey

General Information

Serial Number86319169
Word MarkELUNATEY
Filing DateTuesday, June 24, 2014
Status606 - ABANDONED - NO STATEMENT OF USE FILED
Status DateMonday, January 29, 2018
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4000 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, October 28, 2014

Trademark Statements

Goods and ServicesPharmaceutical preparations, namely, pharmaceutical preparations for the treatment of autoimmune diseases and disorders

Classification Information

International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateTuesday, July 1, 2014
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History

Party NameEli Lilly and Company
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressIndianapolis, IN 46285
Party NameEli Lilly and Company
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressIndianapolis, IN 46285

Trademark Events

Event DateEvent Description
Monday, January 29, 2018ABANDONMENT NOTICE MAILED - NO USE STATEMENT FILED
Monday, January 29, 2018ABANDONMENT - NO USE STATEMENT FILED
Tuesday, June 20, 2017NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Monday, June 19, 2017EXTENSION 5 GRANTED
Friday, June 2, 2017EXTENSION 5 FILED
Wednesday, June 7, 2017CASE ASSIGNED TO INTENT TO USE PARALEGAL
Friday, June 2, 2017TEAS EXTENSION RECEIVED
Thursday, March 9, 2017ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Thursday, March 9, 2017TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Tuesday, January 3, 2017NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Sunday, January 1, 2017EXTENSION 4 GRANTED
Tuesday, November 29, 2016EXTENSION 4 FILED
Tuesday, November 29, 2016TEAS EXTENSION RECEIVED
Tuesday, May 3, 2016NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Saturday, April 30, 2016EXTENSION 3 GRANTED
Friday, March 25, 2016EXTENSION 3 FILED
Sunday, April 24, 2016CASE ASSIGNED TO INTENT TO USE PARALEGAL
Friday, March 25, 2016TEAS EXTENSION RECEIVED
Tuesday, September 29, 2015NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Monday, September 28, 2015EXTENSION 2 GRANTED
Friday, September 18, 2015EXTENSION 2 FILED
Friday, September 25, 2015CASE ASSIGNED TO INTENT TO USE PARALEGAL
Friday, September 18, 2015TEAS EXTENSION RECEIVED
Tuesday, May 26, 2015NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Friday, May 22, 2015EXTENSION 1 GRANTED
Friday, May 22, 2015EXTENSION 1 FILED
Friday, May 22, 2015TEAS EXTENSION RECEIVED
Tuesday, December 23, 2014NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Tuesday, October 28, 2014OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, October 28, 2014PUBLISHED FOR OPPOSITION
Wednesday, October 8, 2014NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Saturday, September 20, 2014APPROVED FOR PUB - PRINCIPAL REGISTER
Friday, September 19, 2014ASSIGNED TO EXAMINER
Tuesday, July 1, 2014NEW APPLICATION OFFICE SUPPLIED DATA ENTERED IN TRAM
Friday, June 27, 2014NEW APPLICATION ENTERED IN TRAM

Related Keywords

elunatey pharmaceutical preparations diseases disorders treatment namely autoimmune